| DISTINGUISHED SPEAKERS AND ADVISORS |
| |
Sarah Abdulla Molokhia, Ph.D.
Director, Pharmacodynamics
iVeena
|
| |
Balamurali K. Ambati, M.D., Ph.D.
Professor
John A. Moran Eye Center
|
| |
Chris Bode, Ph.D.
Vice President
Absorption Systems
|
| |
Ricardo de Carvalho, M.D. Ph.D.
Chief Scientific Officer
3T Ophthalmics |
| |
Glenwood G. Gum, M.S., PhD
Associate Director, Preclinical Laboratory Operations
Absorption Systems |
| |
Patrick Healy, MPH
Chief Executive Officer
Trial Runners
|
| |
John Higuchi
Chief Executive Officer
Aciont |
| |
Konrad Kauper, Ph.D.
Director
Neurotech
|
| |
M. Ken Kengatharan, Ph.D.
President and Chief Scientific Officer
Altheos
|
| |
Achim Krauss, Ph.D.
Director
GlaxoSmithKline
|
| |
Ken Mandell, M.D., Ph.D.
President and Chief Operating Officer
Xcovery Vision
|
| |
Shreelekha Mandal
ORA
|
| |
Mike Patane, Ph.D.
Chief Scientific Officer
EyeGate Pharmaceuticals
|
| |
Samirkumar R. Patel, Ph.D.
School of Chemical & Biomolecular Engineering
Georgia Institute of Technology |
| |
Abraham Scaria, Ph.D.
Senior Scientific Director
Genzyme
|
| |
Susan Schneider, Ph.D.
Director, Discovery Medicine
GlaxoSmithKline Ophthalmology |
| |
Timothy Sullivan
President and Chief Executive Officer
Mystic Pharmaceuticals |
| |
Carol Toris, Ph.D.
Professor and Director, Glaucoma Research
University of Nebraska Medical Center |
| |
Jenny W. Wang, Ph.D.
Principal Scientist
Allergan
|
| |
Barbara Marie Wirostko, M.D.
Chief Medical Officer
Altheos
|
| |
David Woodward, Ph.D
Investigator, Senior RSRCH BI
Allergan |
| |
| Please check back for updates! |